We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Force-Sensing Microbots Designed to Probe Cells

By LabMedica International staff writers
Posted on 23 Oct 2014
Microrobots that have the capability of probing and engineering individual cells and tissue for biological research and medical applications are being constructed with technology that senses the minuscule forces exerted by a robot’s tiny probe. More...


Microrobots small enough to interact with cells already exist. However, there is no easy, inexpensive way to measure the small forces applied to cells by the robots. Measuring these microforces is vital to precisely control the bots and to use them to study cells. “What is needed is a useful tool biologists can use every day and at low cost,” said David Cappelleri, an assistant professor of mechanical engineering at Purdue University (West Lafayette, IN, USA).

Researchers now have devised and constructed a “vision-based micro-force sensor end-effector,” which is attached to the microrobots similar to a tiny proboscis. A camera is used to measure the probe’s displacement while it pushes against cells, allowing a simple calculation that reveals the force applied.

The new strategy could make it possible to easily measure the micronewtons of force applied at the cellular level. Such a tool is needed to better study cells and to understand how they interact with microforces. The forces can be used to convert cells into specific cell lines, including stem cells for research and medical applications. Moreover, the measurement of microforces can be used to examine how cells respond to specific drugs and to diagnose disease.

“You want a device that is low-cost, that can measure micronewton-level forces and that can be easily integrated into standard experimental test beds,” Dr. Cappelleri said. Microrobots used in research are controlled with magnetic fields to move them into place. “But this is the first one with a truly functional end effector to measure microforces,” he said.

The study’s findings were presented during the International Conference on Intelligent Robots and Systems, held in Chicago (IL, USA), September 14–18, 2014.

The new system is combined with the microrobot is about 700 micrometers square, and the researchers are working to create versions about 500 micrometers square. “We are currently working on scaling it down,” Dr. Cappelleri said.

Future research, according to the investigators, also may concentrate on automating the microrobots. The system was fabricated at the Birck Nanotechnology Center in Purdue’s Discovery Park.

Related Links:

Purdue University



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.
Automated Urinalysis Solution
UN-9000
Automated Clinical Chemistry Analyzer
Envoy 500+
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image Credit: iStock

Prehospital Blood Test Could Reduce Emergency Transfers for Chest Pain

Chest pain leads to ambulance transport to an emergency department for about 95% of patients, although only a minority have a serious cardiac condition. Troponin testing helps assess heart muscle damage,... Read more

Molecular Diagnostics

view channel
Image: The method combines metagenomic sequencing with computational filtering to identify likely disease-causing bacteria and viruses (Image Credit: iStock)

Computational Filters Enhance Metagenomic Detection of Meningitis and Encephalitis

Infections of the central nervous system, such as meningitis and encephalitis, can be severe and require prompt diagnosis and treatment. Clinicians typically evaluate cerebrospinal fluid alongside symptoms... Read more

Immunology

view channel
Image: Aptiva utilizes particle-based multi-analyte technology (PMAT) (Photo courtesy of Werfen)

Werfen Expands Automated APS Testing with FDA-Cleared and CE-Marked IgA Reagent

Antiphospholipid syndrome (APS) is an autoimmune disorder associated with thrombosis and pregnancy complications, but its symptoms can overlap with those of other conditions, complicating diagnosis.... Read more

Microbiology

view channel
Image: RealTime Labs’ Mycotoxin Extensive Panel measures 31 mold-related toxins across seven toxin classes from a single urine sample (Photo courtesy of RealTime Labs)

New Urine Test Expands Mycotoxin Analysis to 31 Markers for Broader Exposure Assessment

Clinical evaluation of mold exposure increasingly relies on urinary mycotoxin testing, but limited marker coverage and metabolite masking can make results more difficult to interpret. Broader analysis... Read more

Technology

view channel
Image: ADLM recommends that emerging AI tools follow the same professional oversight, quality, validation, and monitoring standards as traditional clinical testing within CLIA’s existing framework (Image Credit: Adobe Stock)

ADLM Calls for CLIA Updates to Support Safe AI Use in Laboratory Medicine

Clinical laboratories increasingly use artificial intelligence to verify, interpret, and report results, but safeguards under the Clinical Laboratory Improvement Amendments (CLIA) were designed in 1992.... Read more

Industry

view channel
Image

Collaboration Combines AI Cognitive Assessment and RNA Blood Testing for Earlier Alzheimer’s Detection

Alzheimer’s disease is often identified only after substantial neurodegeneration, partly because current diagnostic pathways are fragmented and difficult to scale. As treatment shifts toward earlier intervention,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.